Mark Pruzanski
2019
Compensation breakdown
| Non-Equity Incentive Plan | $560,265 |
|---|---|
| Option Awards | $1,116,118 |
| Salary | $734,292 |
| Stock Awards | $4,197,742 |
| Other | $7,368 |
| Total | $6,615,785 |
Pruzanski received $4.2M in stock awards, accounting for 63% of the total pay in 2019.
Pruzanski also received $560.3K in non-equity incentive plan, $1.1M in option awards, $734.3K in salary and $7.4K in other compensation.
Rankings
In 2019, Mark Pruzanski's compensation ranked 1,477th out of 13,971 executives tracked by ExecPay. In other words, Pruzanski earned more than 89.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,477 out of 13,971 | 89th |
Division Manufacturing | 529 out of 5,701 | 91st |
Major group Chemicals And Allied Products | 162 out of 2,200 | 93rd |
Industry group Drugs | 128 out of 1,886 | 93rd |
Industry Pharmaceutical Preparations | 95 out of 1,398 | 93rd |
Pay ratio
| Mark Pruzanski's Pay | $6,615,785 |
|---|---|
| Median Employee's Pay | $239,066 |
| Pay Ratio | 28to 1 |
In 2019, the annual total compensation of Mark Pruzanski was $6,615,785.
The annual total compensation of the median employee at Intercept Pharmaceuticals was $239,066.
The ratio of Mark Pruzanski's pay to the pay of median employee was therefore 28 to one.
Pruzanski's colleagues
We found four more compensation records of executives who worked with Mark Pruzanski at Intercept Pharmaceuticals in 2019.